COLACI, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.279
EU - Europa 8.554
AS - Asia 1.111
SA - Sud America 29
AF - Africa 14
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.217
IT - Italia 3.566
GB - Regno Unito 2.566
SE - Svezia 759
CN - Cina 451
DE - Germania 428
UA - Ucraina 402
TR - Turchia 325
FR - Francia 305
FI - Finlandia 224
HK - Hong Kong 217
BG - Bulgaria 134
CA - Canada 40
RU - Federazione Russa 34
VN - Vietnam 31
IN - India 25
IE - Irlanda 19
BE - Belgio 18
NL - Olanda 17
CH - Svizzera 15
RO - Romania 15
AR - Argentina 14
BZ - Belize 14
IR - Iran 12
JP - Giappone 12
MY - Malesia 12
AU - Australia 11
PL - Polonia 11
ES - Italia 9
EU - Europa 7
MX - Messico 7
BR - Brasile 6
KR - Corea 6
HU - Ungheria 5
CL - Cile 4
EG - Egitto 4
GR - Grecia 4
SG - Singapore 4
IL - Israele 3
LU - Lussemburgo 3
NO - Norvegia 3
PT - Portogallo 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
SI - Slovenia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CM - Camerun 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
MN - Mongolia 1
PE - Perù 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 21.007
Salva come PNG Salva come JPEG
Città #
Southend 2.236
Fairfield 1.826
Woodbridge 1.068
Houston 830
Ashburn 800
Chandler 751
Jacksonville 723
Seattle 678
Cambridge 599
Wilmington 566
Ann Arbor 532
Dearborn 502
Nyköping 425
Milan 255
Rome 224
Izmir 220
Hong Kong 213
Modena 194
Beijing 153
San Diego 148
Princeton 139
Sofia 132
Eugene 123
Helsinki 119
New York 108
Bremen 73
Redwood City 72
Des Moines 64
London 64
Florence 63
Palermo 60
Bologna 58
Los Angeles 55
Catania 50
Bari 45
Turin 44
San Jose 39
Naples 38
Boardman 35
Atlanta 32
Genoa 32
Shanghai 32
Norwalk 31
Padova 30
Verona 30
Falls Church 26
Cagliari 25
Kunming 24
Dong Ket 20
Brescia 19
Hefei 19
Salerno 19
Reggio Emilia 18
Chiswick 17
Hounslow 17
Dallas 16
Parma 16
Guangzhou 15
Nanjing 15
Belize City 14
Dublin 14
Legnano 14
Ottawa 14
Pisa 14
Chicago 13
Toronto 13
Trento 13
Treviso 13
Brussels 12
Napoli 12
Forlì 11
Hanoi 11
Mountain View 11
Bergamo 10
Cisterna di Latina 10
Indiana 10
Messina 10
Phoenix 10
Frankfurt am Main 9
Livorno 9
Nonantola 9
Perugia 9
Pescara 9
Saint Louis 9
Torino 9
Buenos Aires 8
Genova 8
Islington 8
Jinan 8
Kilburn 8
Prescot 8
Reggio Calabria 8
San Francisco 8
San Mateo 8
Trieste 8
Castelnuovo Rangone 7
Catanzaro 7
Dongguan 7
Leawood 7
Munich 7
Totale 15.184
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 2.557
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 689
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 495
Semeiotica dell'articolazione temporo-mandibolare 310
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 262
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 233
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 222
Current treatment of hepatitis C-associated rheumatic diseases. 218
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 218
Elevated Troponin Serum Levels in Adult Onset Still's Disease 214
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 202
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 200
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 196
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 192
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 192
Aortic pulse wave velocity measurement in systemic sclerosis patients. 191
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 191
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 189
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 188
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 187
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 184
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 182
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 179
New targeted molecular therapies for dedifferentiated thyroid cancer 178
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 176
HCV-related rheumatic manifestations and therapeutic strategies 176
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 176
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 174
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 173
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 171
Associations between Systemic Sclerosis and Thyroid Diseases 170
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 167
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 166
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 166
Renal Manifestations of Hepatitis C Virus 162
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 160
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 159
Endocrine manifestations of hepatitis C virus infection. 158
Scleroderma digital ulcers complicated by infection with fecal pathogens. 157
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 155
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 155
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 153
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 153
Treatment of HCV-related mixed cryoglobulinemia 153
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 152
Heart involvement and systemic sclerosis 151
IP-10 in autoimmune thyroiditis 151
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 151
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 151
The safety of iloprost in systemic sclerosis in a real-life experience 150
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 149
Novel Therapies for Thyroid Autoimmune Diseases 148
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 146
L-Arginine in pregnant scleroderma patients 145
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 144
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 144
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 144
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 143
Severe alopecia complicating systemic sclerosis 143
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 143
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 143
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 142
Osteomyelitis complicating scleroderma digital ulcers. 141
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 140
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 140
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 140
Platelet gel in the treatment of severe scleroderma skin ulcers. 138
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 137
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 137
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 136
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 135
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 134
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 132
Serum a-Chemokine CXCL10 and b-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia 131
Cardiovascular risk and prostanoids in systemic sclerosis 130
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 128
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 127
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 127
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 126
Thymus alterations and systemic sclerosis 126
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 124
RET TKI: potential role in thyroid cancers. 123
CXCL10 in psoriasis 123
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 123
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 123
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 122
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. 122
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 120
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 119
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 119
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 118
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 117
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 117
Mixed cryoglobulinemia syndrome: where are we going to? 111
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 111
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 110
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 110
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 108
Innovative use of magnesium oxide in the treatment of "neuralgia of the celiac plexus of rheumatic origin" by G. Moscati in 1923 108
Impegno cardiaco nella sclerosi sistemica 107
Totale 18.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.515 0 0 0 0 0 0 0 0 0 200 479 836
2019/20204.695 462 192 156 259 422 850 684 621 473 153 259 164
2020/20214.010 298 123 254 352 391 481 429 560 169 398 330 225
2021/20222.636 114 259 280 204 100 181 140 135 280 223 390 330
2022/20233.426 395 246 182 231 401 421 209 307 426 133 299 176
2023/20242.479 134 196 196 345 503 260 290 308 88 159 0 0
Totale 21.293